571 related articles for article (PubMed ID: 35600880)
1. Exploring the Therapeutic Potential of Phytochemicals in Alzheimer's Disease: Focus on Polyphenols and Monoterpenes.
Piccialli I; Tedeschi V; Caputo L; D'Errico S; Ciccone R; De Feo V; Secondo A; Pannaccione A
Front Pharmacol; 2022; 13():876614. PubMed ID: 35600880
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
3. Multi-Target Mechanisms of Phytochemicals in Alzheimer's Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation.
Sharifi-Rad J; Rapposelli S; Sestito S; Herrera-Bravo J; Arancibia-Diaz A; Salazar LA; Yeskaliyeva B; Beyatli A; Leyva-Gómez G; González-Contreras C; Gürer ES; Martorell M; Calina D
J Pers Med; 2022 Sep; 12(9):. PubMed ID: 36143299
[TBL] [Abstract][Full Text] [Related]
4. Natural products against Alzheimer's disease: Pharmaco-therapeutics and biotechnological interventions.
Dey A; Bhattacharya R; Mukherjee A; Pandey DK
Biotechnol Adv; 2017; 35(2):178-216. PubMed ID: 28043897
[TBL] [Abstract][Full Text] [Related]
5. History in Perspective: The prime pathological players and role of phytochemicals in Alzheimer's disease.
Sajad M; Kumar R; Thakur SC
IBRO Neurosci Rep; 2022 Jun; 12():377-389. PubMed ID: 35586776
[TBL] [Abstract][Full Text] [Related]
6. Exploring the Anti-Neuroinflammatory Potential of Steroid and Terpenoid-Derived Phytochemicals to Combat Alzheimer's Disease.
Kabir MT; Uddin MS; Zaman S; Rahman MS; Behl T; Ahmad A; Hafeez A; Perveen A; Ashraf GM
Curr Pharm Des; 2021; 27(22):2635-2647. PubMed ID: 33463452
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's Disease and other Tauopathies: Exploring Efficacy of Medicinal Plant-derived Compounds in Alleviating Tau-mediated Neurodegeneration.
Durairajan SSK; Selvarasu K; Bera MR; Rajaram K; Iyaswamy A; Li M
Curr Mol Pharmacol; 2022; 15(2):361-379. PubMed ID: 34488602
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
9. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
Chen Z; Zhong C
Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
[TBL] [Abstract][Full Text] [Related]
10. Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer's disease.
Kazim SF; Iqbal K
Mol Neurodegener; 2016 Jul; 11(1):50. PubMed ID: 27400746
[TBL] [Abstract][Full Text] [Related]
11. Phytochemicals Targeting Oxidative Stress, Interconnected Neuroinflammatory, and Neuroapoptotic Pathways Following Radiation.
Fakhri S; Piri S; Moradi SZ; Khan H
Curr Neuropharmacol; 2022; 20(5):836-856. PubMed ID: 34370636
[TBL] [Abstract][Full Text] [Related]
12. Exploring Potential of Alkaloidal Phytochemicals Targeting Neuroinflammatory Signaling of Alzheimer's Disease.
Uddin MS; Kabir MT; Al Mamun A; Behl T; Mansouri RA; Aloqbi AA; Perveen A; Hafeez A; Ashraf GM
Curr Pharm Des; 2021; 27(3):357-366. PubMed ID: 32473620
[TBL] [Abstract][Full Text] [Related]
13. Development of grape polyphenols as multi-targeting strategies for Alzheimer's disease.
El Gaamouch F; Liu K; Lin HY; Wu C; Wang J
Neurochem Int; 2021 Jul; 147():105046. PubMed ID: 33872681
[TBL] [Abstract][Full Text] [Related]
14. Multi-potent Natural Scaffolds Targeting Amyloid Cascade: In Search of Alzheimer's Disease Therapeutics.
Chakraborty S
Curr Top Med Chem; 2017; 17(31):3336-3348. PubMed ID: 29345580
[TBL] [Abstract][Full Text] [Related]
15. Neuroinflammation in pathogenesis of Alzheimer's disease: Phytochemicals as potential therapeutics.
Vaiserman A; Koliada A; Lushchak O
Mech Ageing Dev; 2020 Jul; 189():111259. PubMed ID: 32450086
[TBL] [Abstract][Full Text] [Related]
16. Tea polyphenols as multi-target therapeutics for Alzheimer's disease: An in silico study.
Mazumder MK; Choudhury S
Med Hypotheses; 2019 Apr; 125():94-99. PubMed ID: 30902161
[TBL] [Abstract][Full Text] [Related]
17. A review on ferulic acid and analogs based scaffolds for the management of Alzheimer's disease.
Singh YP; Rai H; Singh G; Singh GK; Mishra S; Kumar S; Srikrishna S; Modi G
Eur J Med Chem; 2021 Apr; 215():113278. PubMed ID: 33662757
[TBL] [Abstract][Full Text] [Related]
18. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
Wu X; Kosaraju J; Zhou W; Tam KY
Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Strategies Targeting Amyloid-β in Alzheimer's Disease.
Pinheiro L; Faustino C
Curr Alzheimer Res; 2019; 16(5):418-452. PubMed ID: 30907320
[TBL] [Abstract][Full Text] [Related]
20. A Synthetic Pro-Drug Peptide Reverses Amyloid-β-Induced Toxicity in the Rat Model of Alzheimer's Disease.
Kumar S; Srivastav S; Fatima M; Giri RS; Mandal B; Mondal AC
J Alzheimers Dis; 2019; 69(2):499-512. PubMed ID: 30958369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
